{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-004539","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2024-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.939203+00:00","generated_at":"2026-06-06T10:50:15.375510+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Palisade Bio exercises warrants for $2.5M gross proceeds; exercise price reduced to $0.7313","bullets":["Exercise of ~3.4M Existing Warrants at reduced price of $0.7313 per share, raising ~$2.5M gross.","Replacement Warrants issued for each exercised warrant, exercisable at $0.7313 for 5 years.","Existing warrants initially had exercise prices up to $35.525/share; investors received new warrants.","Ladenburg Thalmann acted as placement agent, earning 7.75% cash fee and 6% warrant coverage.","Net proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-004539","json":"https://secwatch.observer/filing/0001493152-24-004539.json","markdown":"https://secwatch.observer/filing/0001493152-24-004539.md","text":"https://secwatch.observer/filing/0001493152-24-004539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224004539/0001493152-24-004539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224004539/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T10:50:15.375510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0a7fd9a37e4f823bbf49dc80a863059cdda92af4","claim":"PALISADE BIO, INC. entered into warrant inducement agreements with certain accredited and institutional holders valued at approximately $2,502,717 (effective 2024-01-30).","evidence_excerpt":"On January 30, 2024, Palisade Bio, Inc. (the “Company”) entered into warrant inducement agreements (the “Agreements”) with certain accredited and institutional holders (collectively, the “Holders”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224004539/0001493152-24-004539-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"certain accredited and institutional holders"},{"label":"Value","value":"approximately $2,502,717"},{"label":"Effective","value":"2024-01-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}